Gene Query: MCM2

Dataset Description Geneva Score
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 115.33
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 98.09
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 87.77
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 87.77
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 85.07
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 85.07
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 71.18
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 67.3
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 64.95
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 59.34
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 59.02
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 58.06
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 56.94
MYCi361 regulates MYC target genes 54.99
RNA-seq of shEZH2 cells 52.96
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 52.58
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 52.12
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 50.77
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 50.77
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 50.66
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 50.66
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 49.95
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 49.63
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 49.06
Genome wide expression change by RNF168 knocking down in MCF-7 cells 48.02
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 46.65
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 45.0
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 44.72
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 44.72
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 44.61
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 44.45
MCF10A H-Ras RNA-Seq 44.35
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 44.3
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 44.19
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 43.42
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 42.99
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 42.98
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 41.65
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 41.08
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 41.08
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 39.32
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 39.32
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 39.18
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 38.38
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 38.19
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 38.12
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 37.95
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 37.87
Zika infected neural stem cells 37.41
Transcriptome analysis of Zika infected neural stem cells 37.41
Genome-wide transcriptional response to random aneuploidy in human cells 37.28
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 37.22
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 37.09
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 36.97
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 35.92
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 35.92
The landscape of alternative splicing in aggressive prostate cancers 35.71
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 35.28
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 35.07
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 35.07
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 35.03
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 34.99
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 34.95
Endothelial gene expression analysis 34.92
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 34.92
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 34.7
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 34.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 34.41
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 34.17
RNA-seq of resting and activated CD4+ T cells +-JQ1 34.16
Identification of Sin3B regulated genes during quiescence 33.85
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 33.78
Retinoic acid suppresses MYB in adenoid cystic carcinoma 33.78
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 33.74
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 33.67
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 33.67
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 32.76
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 32.7
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 32.56
A549 cells and MSR-A549 cells 32.45
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 32.45
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 31.41
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 31.41
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 31.36
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 31.3
Expression level comparison under dividing and quiescent states in human primary fibroblasts 31.01
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 30.93
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 30.93
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 30.41
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 30.24
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 30.02
hnRNP C is a key regulator of protein synthesis in mitosis 29.93
Gene expression changes caused by KRAS in MCF-10A 29.34
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 29.1
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 28.7
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 28.69
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 28.66
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 28.65
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 28.4
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 28.38
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 27.88
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 27.84
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 27.84
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 27.81
Differentially expressed vascular development genes for iPSC-ECs from CDI 27.67
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 27.61
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 27.61
The regulartory role of ZCCHC24 in splicing machinery 27.52
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 27.4
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 27.36
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 27.19
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 26.85
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 26.8
Effect of CHKA knockdown on C4-2 cell transcriptome 26.78
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 26.77
HBEC-shp53-PCHD7 26.56
Transcriptional profiles of normal human mature B cells 26.52
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 26.48
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 26.42
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 26.42
Paxillin regulates genomic networks in prostate cancer [LNCaP] 26.4
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 26.35
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 26.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 26.24
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 26.07
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 26.01
Role for citron kinase in prostate cancer growth 25.99
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 25.96
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 25.74
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 25.49
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 25.49
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 25.43
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 25.34
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 25.34
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 25.29
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 25.19
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 25.16
A code of mono-phosphorylation modulates the function of RB. 24.97
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 24.94
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 24.84
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 24.7
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 24.58
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 24.58
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 24.45
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 24.19
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 24.12
Genome wide miR-191 target profile determined by RIP and gene expression profiling 23.8
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 23.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 23.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 23.8
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 23.63
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 23.63
CSL RNA-Seq on HKC and SCC cell lines 23.24
CSL 23.24
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 23.05
IRF2 is a master regulator of human keratinocyte stem cell fate 23.05
Systematic discovery of endogenous human ribonucleoprotein complexes 22.99
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 22.94
Neurofibroma 22.78
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 22.78
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 22.72
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 22.68
Identification of global regulators of T-helper cell lineage specification 22.68
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 22.16
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 22.07
IL-33 activates tumor stroma to promote intestinal polyposis 22.04
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 22.01
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 21.92
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 21.8
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 21.8
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 21.77
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 21.74
Overexpression and knockdown experiment for circCSNK1G3 21.71
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 21.69
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 21.69
Dtx3L and Androgen Signaling in Prostate Cancer 21.66
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 21.66
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 21.64
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 21.64
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 21.55
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 21.51
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 21.51
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 21.47
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 21.37
Conservative alteration of chromosomal expression pattern across human solid tumor types 21.35
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 21.33
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 21.33
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 21.33
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 21.17
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 21.17
Identification of HOXB13 target genes responsive to BET inhibitors 21.16
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 21.04
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 21.04
Genome-wide analysis of Dengue virus 2 infected cells 20.76
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 20.69
DJ-1 is dispensable for human stem cell homeostasis 20.68
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 20.62
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 20.51
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 20.23
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 20.17
Aneuploidy triggers an immune response 20.13
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 20.06
RNA-sequencing in irradiated and normal A549 cells. 20.06
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 19.91
Tyrosine Kinase Inhibitor Cardiotoxicity 19.87
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 19.87
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 19.81
Active translatome profiling with RiboLace in MCF7 cells 19.6
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 19.53
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 19.53
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 19.47
Chromatin landscape of human visceral and subcutaneous adipocytes 19.46
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 19.44
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 19.44
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 19.42
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 19.37
Gene expression analysis of dengue-infected cells 19.32
Landscape of H3K4me3 in human CD19 cells 19.31
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 19.31
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 19.24
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 19.17
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 19.14
Aneuploidy-induced cellular stresses limit autophagic degradation. 19.04
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 18.97
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 18.97
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 18.92
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 18.92
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 18.92
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 18.92
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 18.85
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 18.72
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 18.68
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 18.65
Global analyses of the effect of different cellular contexts on microRNA targeting 18.47
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 18.47
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 18.46
MicroRNA targetome analysis during HCMV infection 18.4
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 18.3
Transcriptome analysis of U87 cells upon LINC00152 knockdown 18.18
FOXP2's impact on the primate transcriptome 18.12
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 18.06
Irf9 function in immunity in mouse 18.06
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 18.05
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 18.03
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 18.02
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 18.02
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 18.01
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 17.96
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 17.88
RNAseq of IL-36 stimulated primary human keratinocytes 17.81
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 17.68
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 17.66
Effect of Influenza virus infection on lncRNA expression in A549 cells 17.63
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 17.61
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 17.4
A map of gene expression in neutrophil-like cell lines 17.26
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 17.13
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 17.12
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 17.11
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 17.08
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 17.07
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 17.06
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 17.03
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 17.02
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 16.97
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 16.97
EGR1-controlled transcriptome of T HESCs 16.9
mRNA-Seq profiling of human developing kidney 16.9
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 16.8
RNA-sequencing in immortalized human mammary epithelial cells 16.8
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 16.75
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 16.75
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 16.75
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 16.74
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 16.74
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 16.68
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 16.68
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 16.64
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 16.52
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 16.51
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 16.49
Transcriptome analysis of BAP1 knockout and restoration 16.49
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 16.49
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 16.31
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 16.23
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 16.19
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 16.18
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 16.07
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 16.06
Integrin signaling regulates YAP/TAZ to control skin homeostasis 16.0
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 15.96
NR2F2 study 15.88
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 15.88
Mitochondrial dsRNA triggers antiviral signalling in humans 15.79
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 15.76
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 15.63
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 15.41
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 15.37
Downregulation of DDX5/DDX17 and REST 15.22
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 15.17
Genome-wide chromatin analysis of Ewing sarcoma 15.16
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 15.16
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 15.14
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 15.11
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 15.11
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 14.99
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 14.93
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 14.89
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 14.89
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.88
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 14.87
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 14.76
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 14.72
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 14.72
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 14.67
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 14.64
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 14.59
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 14.57
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 14.57
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 14.53
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 14.51
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 14.44
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 14.44
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 14.41
Widespread intronic polyadenylation diversifies immune cell transcriptomes 14.31
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 14.22
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 14.2
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 14.18
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 14.17
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 14.17
Exploring ILF2 regulatory genes by next-generation sequencing 13.87
High level DNA repair gene expression in human ES cells 13.78
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 13.76
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 13.73
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 13.66
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 13.57
Studying the selectivity of a small molecule Synucleozid on transcriptome 13.48
RNA-seq differential expression studies: more sequence, or more replication? 13.44
Human cells contain natural double-stranded RNAs with potential regulatory capacity 13.38
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 13.35
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 12.97
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 12.94
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 12.89
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 12.89
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 12.87
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 12.72
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 12.43
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 12.43
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 12.32
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 12.11
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 12.11
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 11.9
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 11.67
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 11.67
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 11.63
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 11.59
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 11.48
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 11.39
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 11.29
Gene expression patterns define the hepatocyte-like cells derived by different strategies 11.29
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 11.12
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 11.1
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 10.95
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 10.81
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 10.8
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 10.8
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.77
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 10.75
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.66
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 10.56
The cytokine environment influence on human skin-derived T cells 10.45
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 10.33
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 10.28
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 9.96
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 9.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 9.74
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 9.74
Differential responses of human fetal brain neural stem cells to Zika virus infection 9.72
EWS-Fli and LNC regulated genes in comparison to GFP samples 9.68
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 9.64
The pioneer factor CEBPA modulates vitamin D signaling 9.64
Androgen Receptor-regulated genes in prostate cancer cells 9.23
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 9.23
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 9.19
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 9.18
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 9.11
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 9.11
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 9.05
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 8.99
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.88
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 8.62
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 8.58
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 8.56
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 8.47
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 8.42
Selective expression of long non-coding RNAs in a breast cancer cell progression model 8.29
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 8.1
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 8.1
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 8.06
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 8.06
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 8.01
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.96
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 7.92
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 7.86
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 7.78
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 7.7
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 7.66
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 7.52
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 7.51
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 7.43
6mer seed toxicity in tumour suppressive microRNAs 7.37
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 7.08
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 7.08
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 7.08
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 7.08
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 6.86
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 6.68
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 6.68
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 6.6
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.42
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 6.35
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 6.22
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 6.18
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.03
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.98
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.95
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 5.77
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.41
TAF1 is critical for AE driven leukemogenesis 5.41
6mer seed toxicity in viral microRNAs 5.34
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 5.26
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.08
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 5.03
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.85
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.65
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.46
Exogenous rescue of KLHL9 in SF210 cell line 4.44
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.36
Global response to chemotherapy-induced apoptosis 4.31
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.12
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 4.12
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 4.12
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 4.07
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.04
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 3.91
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.9
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.9
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.61
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.58
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.55
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.53
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 3.45
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 3.38
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.3
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.3
O-glcnAc reprograms cellular energetics 3.29
Global transcriptome analysis of WT versus HEB-/- hESCs 3.28
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 3.24
Profiling of escape kinetics of viruses subjected to RNAi 3.12
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.12
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.07
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.03
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.7
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.65
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.64
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.59
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.24
iPSC derived motor neuron cultures from C9ORF72 carriers 2.15
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 2.07
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.05
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.05
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 2.05
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 2.05
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.98
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.94
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.94
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.78
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.78
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.74
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.7
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.61
ARID1A and ARID1B loss in HCT116 cells 1.59
Effect of from Human Umbilical Vein Endothelial Cells 1.5
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.39
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.37
Gene expression profile of CRC-derived HILEC 1.35
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.28
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.01
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.0
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.94
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.81
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.79
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.79
Proliferation-correlated expression 0.67
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.59
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.3
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.13
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.04
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.04
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation